{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:12:49Z","timestamp":1778883169255,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013041","name":"Vice-Chancellor for Research, Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["1634"],"award-info":[{"award-number":["1634"]}],"id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 diabetes is a common non-communicable disease that is responsible for about 9% of all deaths and a 25% reduction in life expectancy. However, nearly half of the diabetic patients are not aware of their disease. In this regard, to identify un-known diabetic patients, diabetes screening is of great importance. This study was conducted to evaluate the performance of two commonly used diabetes screening tests that are currently recommended by the Iranian diabetes screening program for (DSP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The validity of the two diabetes screening tests were measured among 1057 participants who were older than 30\u00a0years of age. The studied screening tests included capillary fasting blood glucose (CBG) and glycated hemoglobin (HbA1c). The golden standard for measuring the validity of the tests was venous fasting plasma glucose (VPG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>According to the results, the sensitivity of CBG and HbA1c tests was 69.01% and 84.5%, and the specificity of the tests were 95.7% and 79.3%, respectively. Positive and negative predictive values were 53.84% and 97.72% for CBG and 22.72% and 98.61% for HbA1c, respectively. The recommended cut points for CBG and HbA1c were 116.5\u00a0mg\/dl and 7.15%, respectively. Using these values as the new cut points, sensitivity and specificity of CBG and HbA1c changed to 80.30% and 89.10%, and 77.50% and 94.20%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared to several other countries, the performance of Iranian DSP is relatively better. The Receiver Operating Characteristic Curve suggested new cut points for significantly better performance of DSP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13098-021-00632-9","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T05:03:36Z","timestamp":1611637416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Performance of diabetes screening tests: an evaluation study of Iranian diabetes screening program"],"prefix":"10.1186","volume":"13","author":[{"given":"Fateme","family":"Kianpour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Fararouei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jafar","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadnabi","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Dianatinasab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,26]]},"reference":[{"key":"632_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","volume":"10","author":"MAB Khan","year":"2019","unstructured":"Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al KJ. Epidemiology of type 2 diabetes\u2014global burden of disease and forecasted trends. J Epidemiol Glob Health. 2019;10:107\u201311.","journal-title":"J Epidemiol Glob Health"},{"key":"632_CR2","first-page":"1386","volume-title":"Williams textbook of endocrinology","author":"S Melmed","year":"2016","unstructured":"Melmed S. Williams textbook of endocrinology, vol. 13. Philadelphia: Elsevier; 2016. p. 1386."},{"issue":"1","key":"632_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5114\/aoms.2010.13503","volume":"6","author":"A Baghaei","year":"2010","unstructured":"Baghaei A, Sarrafzadegan N, Rabiei K, Gharipour M, Tavasoli AA, Shirani S, et al. How effective are strategies for non-communicable disease prevention and control in a high risk population in a developing country? Isfahan Healthy Heart Programme. Arch Med Sci. 2010;6(1):24\u201331.","journal-title":"Arch Med Sci"},{"issue":"2","key":"632_CR4","first-page":"157","volume":"13","author":"H Faramarzi","year":"2011","unstructured":"Faramarzi H, Bagheri P, Bahrampour A, Halimi L. The comparison of prevalence of diabete and hypertension between rural areas of fars and rural area of EMRO region. Iran J Endocrinol Metab. 2011;13(2):157\u201364.","journal-title":"Iran J Endocrinol Metab"},{"issue":"1","key":"632_CR5","first-page":"9","volume":"3","author":"Z Salem","year":"2004","unstructured":"Salem Z, Neshat A, Bagherian K, Sheykh Fath Elahi M, Sajadi M. Prevalence of type II diabetes mellitus in over 30 year old population of Rafsanjan city in the year 2000. J Rafsanjan Univ Med Sci. 2004;3(1):9\u201316.","journal-title":"J Rafsanjan Univ Med Sci"},{"issue":"2","key":"632_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","volume":"3","author":"AD Shah","year":"2015","unstructured":"Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people. Lancet Diabetes Endocrinol. 2015;3(2):105\u201313.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"18","key":"632_CR7","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","volume":"373","author":"M Tancredi","year":"2015","unstructured":"Tancredi M, Rosengren A, Svensson A-M, Kosiborod M, Pivodic A, Gudbj\u00f6rnsdottir S, et al. Excess mortality among persons with type 2 diabetes. N Engl J Med. 2015;373(18):1720\u201332.","journal-title":"N Engl J Med"},{"issue":"10027","key":"632_CR8","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","volume":"387","author":"B Zhou","year":"2016","unstructured":"Zhou B, Lu Y, Hajifathalian K, Bentham J, Di Cesare M, Danaei G, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513\u201330.","journal-title":"Lancet"},{"issue":"3","key":"632_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1586\/14737159.2016.1133299","volume":"16","author":"W Jia","year":"2016","unstructured":"Jia W. Standardising HbA1c-based diabetes diagnosis: opportunities and challenges. Expert Rev Mol Diagn. 2016;16(3):343\u201355.","journal-title":"Expert Rev Mol Diagn"},{"issue":"6","key":"632_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4093\/dmj.2018.0047","volume":"42","author":"H Ghaem","year":"2018","unstructured":"Ghaem H, Daneshi N, Riahi S, Dianatinasab M. The prevalence and risk factors for diabetic retinopathy in Shiraz, Southern Iran. Diabetes Metab J. 2018;42(6):538\u201343.","journal-title":"Diabetes Metab J"},{"issue":"17","key":"632_CR11","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1001\/jama.2014.3201","volume":"311","author":"D Dabelea","year":"2014","unstructured":"Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311(17):1778\u201386.","journal-title":"JAMA"},{"key":"632_CR12","unstructured":"International Diabetes Federation IDF Diabetes Atlas 2012. 6th edition. http:\/\/www.idf.org\/diabetesatlas."},{"issue":"4","key":"632_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4103\/0973-3930.57348","volume":"29","author":"SK Gupta","year":"2009","unstructured":"Gupta SK, Singh Z, Purty AJ, Vishwanathan M. Diabetes prevalence and its risk factors in urban Pondicherry. Int J Diabetes Dev Ctries. 2009;29(4):166.","journal-title":"Int J Diabetes Dev Ctries"},{"issue":"3","key":"632_CR14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.4103\/0970-0218.69262","volume":"35","author":"SK Gupta","year":"2010","unstructured":"Gupta SK, Singh Z, Purty AJ, Kar M, Vedapriya D, Mahajan P, et al. Diabetes prevalence and its risk factors in rural area of Tamil Nadu. Indian J Community Med. 2010;35(3):396.","journal-title":"Indian J Community Med"},{"issue":"8","key":"632_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s40273-015-0268-9","volume":"33","author":"T Seuring","year":"2015","unstructured":"Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics. 2015;33(8):811\u201331.","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"632_CR16","first-page":"103","volume":"7","author":"T Azizi","year":"2005","unstructured":"Azizi T, Harati H, Mirbolooki M, Saadat N, Azizi F. Association of different anthropometric measures and type 2 diabetes in an Iranian urban population. Iran J Endocrinol Metab. 2005;7(2):103\u201310.","journal-title":"Iran J Endocrinol Metab"},{"key":"632_CR17","unstructured":"World Health Organization. Global report on diabetes. Geneva: World Health Organization. 2016. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes. Accessed 21 July 2017."},{"key":"632_CR18","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.jcjd.2017.10.004","volume":"42","author":"J-M Ekoe","year":"2018","unstructured":"Ekoe J-M, Goldenberg R, Katz P. Screening for diabetes in adults. Can J Diabetes. 2018;42:S16\u20139.","journal-title":"Can J Diabetes"},{"issue":"7","key":"632_CR19","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2337\/diacare.15.7.815","volume":"15","author":"MI Harris","year":"1992","unstructured":"Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4\u20137 yr before clinical diagnosis. Diabetes Care. 1992;15(7):815\u20139.","journal-title":"Diabetes Care"},{"issue":"6","key":"632_CR20","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.2337\/dc13-2101","volume":"37","author":"M Porta","year":"2014","unstructured":"Porta M, Curletto G, Cipullo D, de la Longrais RR, Trento M, Passera P, et al. Estimating the delay between onset and diagnosis of type 2 diabetes from the time course of retinopathy prevalence. Diabetes Care. 2014;37(6):1668\u201374.","journal-title":"Diabetes Care"},{"key":"632_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6989453","author":"K Papatheodorou","year":"2015","unstructured":"Papatheodorou K, Banach M, Edmonds M, Papanas N, Papazoglou D. Complications of diabetes. Hindawi. 2015. https:\/\/doi.org\/10.1155\/2015\/189525.","journal-title":"Hindawi"},{"key":"632_CR22","volume-title":"Diabetes","author":"D Mathur","year":"2008","unstructured":"Mathur D, Santoyo-Olsson J, Stewart A, Freyre R, Grossman M, Saavedra J, et al. Using capillary blood glucose for eligibility screening in community-based diabetes prevention study. In: Diabetes. Alexandria: AMER DIABETES ASSOC; 2008."},{"key":"632_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/1471-2458-12-349","volume":"12","author":"B Muktabhant","year":"2012","unstructured":"Muktabhant B, Sanchaisuriya P, Sarakarn P, Tawityanon W, Trakulwong M, Worawat S, et al. Use of glucometer and fasting blood glucose as screening tools for diabetes mellitus type 2 and glycated haemoglobin as clinical reference in rural community primary care settings of a middle income country. BMC Public Health. 2012;12:349.","journal-title":"BMC Public Health"},{"issue":"1","key":"632_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00592-015-0761-9","volume":"53","author":"B Bhavadharini","year":"2016","unstructured":"Bhavadharini B, Mahalakshmi MM, Maheswari K, Kalaiyarasi G, Anjana RM, Deepa M, et al. Use of capillary blood glucose for screening for gestational diabetes mellitus in resource-constrained settings. Acta Diabetol. 2016;53(1):91\u20137.","journal-title":"Acta Diabetol"},{"key":"632_CR25","unstructured":"WHO. Diabetes country profiles 2016. https:\/\/www.who.int\/diabetes\/country-profiles\/irn_en.pdf?ua=1. Accessed 5 Aug 2019."},{"issue":"4","key":"632_CR26","first-page":"1","volume":"12","author":"M Zakerkish","year":"2013","unstructured":"Zakerkish M, Rahimi N, Marefati H, Kovsarian Z. Evaluation of cardiovascular risk factors in diabetic patients in two regions with differences in race, culture and climate. Jundishapur Sci Med J. 2013;12(4):1\u201311.","journal-title":"Jundishapur Sci Med J"},{"issue":"2","key":"632_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/dme.13118","volume":"34","author":"E Bertran","year":"2017","unstructured":"Bertran E, Berlie H, Taylor A, Divine G, Jaber L. Diagnostic performance of HbA1c for diabetes in Arab vs. European populations: a systematic review and meta-analysis. Diabetic Med. 2017;34(2):156\u201366.","journal-title":"Diabetic Med"},{"key":"632_CR28","first-page":"73","volume-title":"Epidemiology textbook of prevalence disease in Iran","author":"P Yavari","year":"2014","unstructured":"Yavari P. Diabetes. In: Epidemiology textbook of prevalence disease in Iran, vol. 2. Tehran: Gapnashr; 2014. p. 73\u201384."},{"key":"632_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jbi.2014.02.013","volume":"48","author":"K Hajian-Tilaki","year":"2014","unstructured":"Hajian-Tilaki K. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inform. 2014;48:193\u2013204.","journal-title":"J Biomed Inform"},{"issue":"11","key":"632_CR30","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","volume":"26","author":"S Genuth","year":"2003","unstructured":"Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26(11):3160\u20137.","journal-title":"Diabetes Care"},{"issue":"2","key":"632_CR31","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2337\/dc10-1546","volume":"34","author":"DB Sacks","year":"2011","unstructured":"Sacks DB. A1C versus glucose testing: a comparison. Diabetes Care. 2011;34(2):518\u201323.","journal-title":"Diabetes Care"},{"issue":"4","key":"632_CR32","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1177\/193229680900300446","volume":"3","author":"K Tonyushkina","year":"2009","unstructured":"Tonyushkina K, Nichols JH. Glucose meters: a review of technical challenges to obtaining accurate results. J Diabetes Sci Technol. 2009;3(4):971\u201380.","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"632_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/BF01223157","volume":"16","author":"NB Rushforth","year":"1979","unstructured":"Rushforth NB, Miller M, Bennett PH. Fasting and two-hour post-load glucose levels for the diagnosis of diabetes. The relationship between glucose levels and complications of diabetes in the Pima Indians. Diabetologia. 1979;16(6):373\u20139.","journal-title":"Diabetologia"},{"issue":"Supplement 1","key":"632_CR34","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Supplement 1):S81\u201390.","journal-title":"Diabetes Care"},{"issue":"Pt 1","key":"632_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/0004563213487893","volume":"51","author":"M Parwaiz","year":"2014","unstructured":"Parwaiz M, Lunt H, Florkowski CM, Logan FJ, Irons L, Perwick C, et al. Assessment of glucose meter performance at the antenatal diabetes clinic: exploration of patient-related and pre-analytical factors. Ann Clin Biochem. 2014;51(Pt 1):47\u201353.","journal-title":"Ann Clin Biochem"},{"issue":"9","key":"632_CR36","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.2337\/dc10-0679","volume":"33","author":"C Lorenzo","year":"2010","unstructured":"Lorenzo C, Wagenknecht LE, Hanley AJG, Rewers MJ, Karter AJ, Haffner SM. A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the insulin resistance atherosclerosis study (IRAS). Diabetes Care. 2010;33(9):2104\u20139.","journal-title":"Diabetes Care"},{"key":"632_CR37","first-page":"33","volume":"7","author":"H Farahani","year":"2005","unstructured":"Farahani H, Naeimi A. Comparison of glycosylated hemoglobin and oral glucose tolerance test in diagnosis of diabetes in person with impaired fasting glucose. Arak Med Univ J. 2005;7:33\u20138.","journal-title":"Arak Med Univ J"},{"key":"632_CR38","first-page":"321","volume-title":"An introductory text epidemiology","author":"J Mausner","year":"2010","unstructured":"Mausner J, Kramer S. Screening for disease detection. In: Janghorbani M, editor. An introductory text epidemiology, vol. 1. Kerman: Cultural Services Publishing; 2010. p. 321\u201354."},{"key":"632_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.diabres.2011.03.012","volume":"93","author":"WHO","year":"2011","unstructured":"WHO. Report of a World Health Organisation Consultation: use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract. 2011;93:299\u2013309.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"632_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2337\/dc14-1179","volume":"38","author":"AE Sumner","year":"2015","unstructured":"Sumner AE, Thoreson CK, O\u2019Connor MY, Ricks M, Chung ST, Tulloch-Reid MK, et al. Detection of abnormal glucose tolerance in Africans is improved by combining A1C with fasting glucose: the Africans in America Study. Diabetes Care. 2015;38(2):213\u20139.","journal-title":"Diabetes Care"},{"issue":"1","key":"632_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00125-008-1157-y","volume":"52","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2009;52(1):17\u201330.","journal-title":"Diabetologia"},{"issue":"3","key":"632_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2337\/dc09-1694","volume":"33","author":"V Mohan","year":"2010","unstructured":"Mohan V, Vijayachandrika V, Gokulakrishnan K, Anjana RM, Ganesan A, Weber MB, et al. A1C cut points to define various glucose intolerance groups in Asian Indians. Diabetes Care. 2010;33(3):515\u20139.","journal-title":"Diabetes Care"},{"issue":"5","key":"632_CR43","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1089\/met.2013.0128","volume":"12","author":"F Guo","year":"2014","unstructured":"Guo F, Moellering DR, Garvey WT. Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-hr glucose values and effects of gender, race, and age. Metab Syndr Relat Disord. 2014;12(5):258\u201368.","journal-title":"Metab Syndr Relat Disord"},{"issue":"8","key":"632_CR44","doi-asserted-by":"publisher","first-page":"e22558","DOI":"10.1371\/journal.pone.0022558","volume":"6","author":"AE Zemlin","year":"2011","unstructured":"Zemlin AE, Matsha TE, Hassan MS, Erasmus RT. HbA1c of 6.5% to diagnose diabetes mellitus\u2014does it work for us? The Bellville South Africa study. PLoS ONE. 2011;6(8):e22558.","journal-title":"PLoS ONE"},{"issue":"8","key":"632_CR45","doi-asserted-by":"publisher","first-page":"e0161966","DOI":"10.1371\/journal.pone.0161966","volume":"11","author":"TR Hird","year":"2016","unstructured":"Hird TR, Pirie FJ, Esterhuizen TM, O\u2019Leary B, McCarthy MI, Young EH, et al. Burden of diabetes and first evidence for the utility of HbA1c for diagnosis and detection of diabetes in urban black South Africans: the Durban diabetes study. PLoS ONE. 2016;11(8):e0161966.","journal-title":"PLoS ONE"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-021-00632-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13098-021-00632-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-021-00632-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T05:10:17Z","timestamp":1611637817000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-021-00632-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,26]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["632"],"URL":"https:\/\/doi.org\/10.1186\/s13098-021-00632-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.11503\/v1","asserted-by":"object"}]},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,26]]},"assertion":[{"value":"26 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research proposal was approved by the Ethics Committee affiliated with Shiraz University of Medical Sciences (Approval Code: SUMS 10908).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}